Osteoporosis Trial, Recruiting NCT07508553 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT07508553
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have signed a consent form and are willing to take part and complete the study questionnaires
  • Pregnant women who are between 35 and 41 weeks along at the time of joining the study
  • Women carrying one baby or twins (including both types of twin pregnancies)
  • Women aged between 30 and 45 years at the time of joining the study
  • Women with no history of broken bones (including from injury) and no movement or mobility difficulties
  • Women who have not been diagnosed with low bone density or bone-thinning conditions, based on Italian medical guidelines
  • Women who have not taken vitamin D supplements or any other medications during pregnancy
  • Women with no current or past health conditions that could affect bone health (such as thyroid, kidney, or liver problems)
  • Women with a body weight in the normal range or with mild obesity — specifically, a body mass index (BMI) between 18.5 and 34

Who may not be able to join:

  • Women who do not sign the consent form or are unable or unwilling to complete the study questionnaires
  • Women who have existing health conditions or who develop new health conditions during pregnancy
  • Women younger than 30 or older than 45 years of age
  • Women who have been previously diagnosed with low bone density or bone-thinning conditions, based on Italian medical guidelines
  • Women with a BMI below 18.5 or above 34

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tullio Ghi, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: 0630155989

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 December 2025
Est. completion
23 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

BMD differences between singleton and twin pregnancies

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov